---
title: "Winning Health (300253): Won the procurement project of Qingdao Cardiovascular Hospital Co., Ltd., with a bid amount of 1.38 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288879529.md"
description: "Winning Health announced that it won the bid for the procurement project of Qingdao Cardiovascular Hospital Co., Ltd., with an amount of 1.38 million yuan. The company's revenue in 2025 is 2.106 billion yuan, with a net loss of 374 million yuan; in the first quarter of 2026, the revenue is 397 million yuan, and the net profit turns positive to 14 million yuan"
datetime: "2026-06-05T14:40:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288879529.md)
  - [en](https://longbridge.com/en/news/288879529.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288879529.md)
generator: "portal-rs"
---

# Winning Health (300253): Won the procurement project of Qingdao Cardiovascular Hospital Co., Ltd., with a bid amount of 1.38 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Shandong Port Medical and Health Group Qingdao Cardiovascular Hospital 2026 HIS and Clinical Information System and Related System Maintenance Procurement Project Bid Section 1," Winning Health Technology Group Co., Ltd. announced on June 5, 2026, that it won the procurement project of Qingdao Cardiovascular Hospital Co., Ltd., with a winning amount of 1.38 million yuan.

Related listed company: Winning Health (300253.SZ)

*Tongbi Finance Tip:*

*Winning Health (300253.SZ) had an operating income of 2.106 billion yuan in 2025, with an operating income growth rate of -24.30%. The net profit attributable to the parent company was -374 million yuan, with a net profit growth rate of -525.38%. The return on net assets was -6.44%.*

*In the first quarter of 2026, the company's operating income was 397 million yuan, with an operating income growth rate of 15.21%. The net profit attributable to the parent company was 14 million yuan, with a net profit growth rate of 165.26%.*

*The company currently belongs to the information technology industry, with the main product types being industry-specific software. In the 2025 report, the main business composition was software and services: 82.35%; system integration: 9.17%; internet medical health: 8.49%.*

### Related Stocks

- [300253.CN](https://longbridge.com/en/quote/300253.CN.md)

## Related News & Research

- [Wenzhou Kangning Hospital files HKEX next-day disclosure return on share repurchase for cancellation](https://longbridge.com/en/news/296222248.md)
- [Wenzhou Kangning Hospital announces extraordinary general meeting](https://longbridge.com/en/news/296373310.md)
- [21:30 ET"Superior Products of Qingdao" Features at Panama International Tire & Auto Expo, deepening Footprint in Latin American Market](https://longbridge.com/en/news/295867316.md)
- [Wenzhou Kangning Sets Register Closure Ahead of September EGM](https://longbridge.com/en/news/296083508.md)
- [Wenzhou Kangning Hospital files HKEX next-day return disclosing share repurchase for cancellation](https://longbridge.com/en/news/296122609.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**